Skip to content
Open access · OA via OpenAlex

The role of mTOR signaling in Alzheimer disease

Salvatore Oddo

Frontiers in Bioscience-Scholar · 2012 · ▲ 243 citations

Abstract

The buildup of Abeta and tau is believed to directly cause or contribute to the progressive cognitive deficits characteristic of Alzheimer disease. However, the molecular pathways linking Abeta and tau accumulation to learning and memory deficits remain elusive. There is growing evidence that soluble forms of Abeta and tau can obstruct learning and memory by interfering with several signaling cascades. In this review, I will present data showing that the mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) may play a role in Abeta and tau induced neurodegeneration.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.2741/s310
Canonical
link ↗
Fetched
2026-06-13 MST

Cite this

APA
Oddo, S. (2012). The role of mTOR signaling in Alzheimer disease. <em>Frontiers in Bioscience-Scholar</em>. https://doi.org/10.2741/s310
Vancouver
Oddo S. The role of mTOR signaling in Alzheimer disease. Frontiers in Bioscience-Scholar. 2012. doi:10.2741/s310.
BibTeX
@article{salvatore2012Therol, title = {The role of mTOR signaling in Alzheimer disease}, author = {Salvatore Oddo}, journal = {Frontiers in Bioscience-Scholar}, year = {2012}, doi = {10.2741/s310}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings